Description

Some HIV-positive patients experience a decline in renal function while receiving anti-HIV medications. Kamara et al used several definitions to define rapid progression of a decline in renal function. The authors are members of the D:A:D study group, named for Data Collection on Adverse Events of Anti-HIV Drugs.


Patient selection: HIV-positive patients on anti-HIV medications

 

The GFR was estimated from the serum creatinine and was normalized for body surface area was monitored over 4 years, with minimal set initial, then every year after that for 4 years (minimum serum creatinine measurements 5).

 

The initial eGFR was > 90 mL per min per 1.73 square meters

 

Several followup schedules were evaluated. The following is definition “A”.

 

Conditions for rapid progression – all of the following:

(1) average eGFR decline >= 5 mL per min per 1.73 square meters over the 4 year period

(2) the absolute annual decline in eGFR was >= 5 mL per min per 1.73 square meters per year in 2 consecutive years

(3) The eGFR was < 90 mL per min per 1.73 square meters at the end of the 4 years

 

Performance:

• The sensitivity was 38% and specificity 97%

 

Limitations:

• The Cockroft-Gault formula was used to calculate the eGFR.


To read more or access our algorithms and calculators, please log in or register.